Estimation of renal cell carcinoma treatment effects from disease progression modeling. (Record no. 22537146)

MARC details
000 -LEADER
fixed length control field 01566 a2200409 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250516135548.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201305s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1532-6535
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1038/clpt.2012.263
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Maitland, M L
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20130517
245 00 - TITLE STATEMENT
Title Estimation of renal cell carcinoma treatment effects from disease progression modeling.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Clinical pharmacology and therapeutics
Date of publication, distribution, etc. Apr 2013
300 ## - PHYSICAL DESCRIPTION
Extent 345-51 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Validation Study
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Carcinoma, Renal Cell
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Clinical Trials, Phase II as Topic
General subdivision statistics & numerical data
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Clinical Trials, Phase III as Topic
General subdivision statistics & numerical data
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Disease Progression
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Kidney Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Models, Statistical
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Niacinamide
General subdivision analogs & derivatives
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Phenylurea Compounds
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Sorafenib
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Wu, K
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Sharma, M R
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Jin, Y
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kang, S P
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Stadler, W M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Karrison, T G
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ratain, M J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bies, R R
773 0# - HOST ITEM ENTRY
Title Clinical pharmacology and therapeutics
Related parts vol. 93
-- no. 4
-- p. 345-51
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1038/clpt.2012.263">https://doi.org/10.1038/clpt.2012.263</a>
Public note Available from publisher's website

No items available.